InvestorsHub Logo
Followers 553
Posts 38257
Boards Moderated 3
Alias Born 06/14/2004

Re: None

Wednesday, 10/10/2012 3:28:48 PM

Wednesday, October 10, 2012 3:28:48 PM

Post# of 10237
JAQC .85 - This is the initial stage and this can be a sure long term hold with so much room to grow. JAQC has a huge merger with Russian based Pharmaceutical co Rafarma. They are Russia's largest Pharmaceutical co and have over 100 different drugs.

This could easily be multi dollars in the future.imo Probably a 10 bagger from these current levels. The current value(not reflected in pps as of yet) is over $4.00 a share. The potential here is just mind boggling. This is a type of merger one waits a lifetime for and now its here and at a ground floor opportunity for investors.


Here are some highlights.



Some highlights:

- Only 420K float

- Plant will single handily reduce Russia's foreign drug imports by 30%

- Russian government holds most of the control of the company in its hands

- Funding of the construction of the plant came straight from Vladimir Putin

- Company has been conservatively valued at circa US$300 million.

- Projected Revenues...2012-$15,606,285, 2013-$142,488,845, 2014-$271,488,845

- Will produce 200 different drugs, a mixture of both generics and proprietary medicines, which have already gone through human clinical trials and are ready to go right now.

- Only pharma plant in Russia that is fully compliant with the complete cycle of the world's top pharmaceutical standards.

- Rafarma is a contract manufacture for companies like Abbott, Bristol Myers, Novartis, GlaxoSmithKline, Merck, Roche and BayerAG.

- By 2014 they will have a whopping 33% of the market share in Russia and Eastern Europe for many drugs they produce.




My posts are only my opinion. I don't know the future. Please don't take my posts as investment decisions. You have to do your own Due Diligence and make your own investment choices.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.